View in EDS HTML Full Text PDF Full Text

Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction.

Saved in:
Bibliographic Details
Title: Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction.
Authors: Sullivan R; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada., Hou J; Lakehead University and Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada., Yu L; London Regional Cancer Program, London, Ontario, Canada., Wilk B; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Sykes J; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Biernaski H; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Butler J; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Kovacs M; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Hicks J; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Thiessen JD; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Dharmakumar R; Indiana School of Medicine, Indianapolis, Indiana; and., Prato FS; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada., Wisenberg G; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada., Luyt LG; London Regional Cancer Program, London, Ontario, Canada.; Departments of Chemistry, Oncology, and Medical Imaging, Western University, London, Ontario, Canada., Dhanvantari S; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada; sdhanvan@lawsonimaging.ca.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.
Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1633-1639. Date of Electronic Publication: 2024 Oct 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39266294
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Design, Synthesis, and Preclinical Evaluation of a High-Affinity <superscript>18</superscript>F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sullivan+R%22">Sullivan R</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hou+J%22">Hou J</searchLink>; Lakehead University and Thunder Bay Regional Health Research Institute, Thunder Bay, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Yu+L%22">Yu L</searchLink>; London Regional Cancer Program, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wilk+B%22">Wilk B</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Sykes+J%22">Sykes J</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Biernaski+H%22">Biernaski H</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Butler+J%22">Butler J</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kovacs+M%22">Kovacs M</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Hicks+J%22">Hicks J</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Thiessen+JD%22">Thiessen JD</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Dharmakumar+R%22">Dharmakumar R</searchLink>; Indiana School of Medicine, Indianapolis, Indiana; and.<br /><searchLink fieldCode="AU" term="%22Prato+FS%22">Prato FS</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Wisenberg+G%22">Wisenberg G</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Luyt+LG%22">Luyt LG</searchLink>; London Regional Cancer Program, London, Ontario, Canada.; Departments of Chemistry, Oncology, and Medical Imaging, Western University, London, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Dhanvantari+S%22">Dhanvantari S</searchLink>; Imaging Research Program, Lawson Health Research Institute, London, Ontario, Canada; sdhanvan@lawsonimaging.ca.; Department of Pathology and Laboratory Medicine, Western University, London, Ontario, Canada.; Department of Medical Biophysics, Western University, London, Ontario, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220217410%22">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</searchLink> [J Nucl Med] 2024 Oct 01; Vol. 65 (10), pp. 1633-1639. <i>Date of Electronic Publication: </i>2024 Oct 01.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Society+of+Nuclear+Medicine%22">Society of Nuclear Medicine </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0217410 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1535-5667 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201615505%22">01615505 </searchLink><i>NLM ISO Abbreviation: </i>J Nucl Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39266294
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2967/jnumed.124.267578
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1633
    Titles:
      – TitleFull: Design, Synthesis, and Preclinical Evaluation of a High-Affinity 18F-Labeled Radioligand for Myocardial Growth Hormone Secretagogue Receptor Before and After Myocardial Infarction.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sullivan R
      – PersonEntity:
          Name:
            NameFull: Hou J
      – PersonEntity:
          Name:
            NameFull: Yu L
      – PersonEntity:
          Name:
            NameFull: Wilk B
      – PersonEntity:
          Name:
            NameFull: Sykes J
      – PersonEntity:
          Name:
            NameFull: Biernaski H
      – PersonEntity:
          Name:
            NameFull: Butler J
      – PersonEntity:
          Name:
            NameFull: Kovacs M
      – PersonEntity:
          Name:
            NameFull: Hicks J
      – PersonEntity:
          Name:
            NameFull: Thiessen JD
      – PersonEntity:
          Name:
            NameFull: Dharmakumar R
      – PersonEntity:
          Name:
            NameFull: Prato FS
      – PersonEntity:
          Name:
            NameFull: Wisenberg G
      – PersonEntity:
          Name:
            NameFull: Luyt LG
      – PersonEntity:
          Name:
            NameFull: Dhanvantari S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct 01
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1535-5667
          Numbering:
            – Type: volume
              Value: 65
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
              Type: main
ResultId 1